Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 11, 2014

View Archived Issues

In vivo data for the novel anti-Abeta-oligomer antibody ACU-3B3

Phase II results presented for clazakizumab in patients with active psoriatic arthritis

Endo acquires rights to Natesto testosterone nasal gel

OncoSec Medical confirms phase II trial of ImmunoPulse in head and neck cancer

Zymeworks and Merck & Co. expand bispecific antibody collaboration

MIPS, Monash University and Takeda form strategic research alliance in gastroenterology

Calithera licenses Mars Symbioscience's arginase inhibitors

La Jolla Pharmaceutical and George Washington University sign license agreement relating to LJPC-501

Ono Pharmaceutical presents a novel dual Axl/Mer inhibitor, ONO-9330547

Spark Therapeutics and Pfizer establish gene therapy collaboration in hemophilia B

Bayer and DNDi sign agreement to develop oral drug for river blindness

Alize Pharma reports phase I findings on AZP-531

Myelo-001 for the prevention of chemotherapy-induced myelosuppression

Spanish researchers report development of neuroprotective steroidal nitrones

Roche researchers prepare and test CYP11B2 inhibitors

Chinese institute patents new antiviral compounds

Reslizumab improves quality of life of asthma patients with elevated eosinophils

Luoda Biosciences synthesizes novel kinase inhibitors

FDA approves nine-valent HPV vaccine Gardasil 9

Immunovaccine receives FDA fast track designation for DPX-Survivac

Eculizumab receives orphan drug designation in Japan for myasthenia gravis

FDA grants orphan drug designation to rNAPc2 for Ebola

Preclinical studies show promising results on APG-1252 as a novel Bcl-2/Bcl-xL inhibitor

Ono, BMS and Kyowa Hakko Kirin to conduct combination study of Opdivo

U.K. researchers gain access to 68 deprioritized compounds under MRC program

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...